Net sales of Kimia Farma FY 2023, by product
At the end of financial year 2023, PT Kimia Farma Tbk generated net sales of approximately 1.94 trillion Indonesian rupiah from the sale of third party over the counter (OTC) medicines. Kimia Farma is a subsidiary of PT Bio Farma (Persero), a state-owned pharmaceutical enterprise, and one of the leading companies in the pharmaceutical industry in Indonesia.